Preventing Mislabeling: A Comparative Chromatographic Analysis for Classifying Medical and Industrial Cannabis

Gas chromatography (GC) techniques for analyzing and determining the cannabinoid profile in cannabis (Cannabis sativa L.) are widely used in standard laboratories; however, these methods may mislabel the profile when used under rapid conditions. Our study aimed to highlight this problem and optimize GC column conditions and mass spectrometry (MS) parameters to accurately identify cannabinoids in both standards and forensic samples. The method was validated for linearity, selectivity, and precision. It was observed that when tetrahydrocannabinol (Δ9-THC) and cannabidiolic acid (CBD-A) were examined using rapid GC conditions, the resulting derivatives generated identical retention times. Wider chromatographic conditions were applied. The linear range for each compound ranged from 0.02 μg/mL to 37.50 μg/mL. The R2 values ranged from 0.996 to 0.999. The LOQ values ranged from 0.33 μg/mL to 5.83 μg/mL, and the LOD values ranged from 0.11 μg/mL to 1.92 μg/mL. The precision values ranged from 0.20% to 8.10% RSD. In addition, forensic samples were analyzed using liquid chromatography (HPLC-DAD) in an interlaboratory comparison test, with higher CBD and THC content than GC–MS determination (p < 0.05) in samples. Overall, this study highlights the importance of optimizing GC techniques to avoid mislabeling cannabinoids in cannabis samples.

[1]  F. Shakeel,et al.  GC-MS Analysis, Phytochemical Screening, and Antibacterial Activity of Cerana indica Propolis from Kashmir Region , 2022, Separations.

[2]  M. Ghoneim,et al.  Simultaneous Determination of Fenchone and Trans-Anethole in Essential Oils and Methanolic Extracts of Foeniculum vulgare Mill. Fruits Obtained from Different Geographical Regions Using GC-MS Approach , 2022, Separations.

[3]  D. Joly,et al.  Associations between cannabinoids and growth stages of twelve industrial hemp cultivars grown outdoors in Atlantic Canada , 2021, Industrial Crops and Products.

[4]  S. Vasile,et al.  Hemp (Cannabis sativa L.) for high-value textile applications: The effective long fiber yield and quality of different hemp varieties, processed using industrial flax equipment , 2020 .

[5]  D. Lachenmeier,et al.  Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature , 2020, Toxics.

[6]  F. Priego-Capote,et al.  Untargeted characterization of extracts from Cannabis sativa L. cultivars by gas and liquid chromatography coupled to mass spectrometry in high resolution mode. , 2020, Talanta.

[7]  A. Hernández,et al.  Seeking suitable agronomical practices for industrial hemp (Cannabis sativa L.) cultivation for biomedical applications , 2019, Industrial Crops and Products.

[8]  L. Nahar,et al.  Gas chromatographic analysis of naturally occurring cannabinoids: A review of literature published during the past decade. , 2019, Phytochemical analysis : PCA.

[9]  R. Sabalis,et al.  VIENNA, AUSTRIA: , 2019, Finding Edith.

[10]  M. Abdel-Kader,et al.  Chemical composition of fennel seed extract and determination of fenchone in commercial formulations by GC–MS method , 2019, Journal of Food Science and Technology.

[11]  W. Weinmann,et al.  Quantitative determination of CBD and THC and their acid precursors in confiscated cannabis samples by HPLC-DAD. , 2019, Forensic science international.

[12]  W. Weinmann,et al.  Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a “tobacco substitute” , 2019, International Journal of Legal Medicine.

[13]  M. Memo,et al.  Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. , 2018, Journal of ethnopharmacology.

[14]  L. A. Ciolino,et al.  Commercial cannabis consumer products part 1: GC-MS qualitative analysis of cannabis cannabinoids. , 2018, Forensic science international.

[15]  D. Friedman,et al.  Pharmacology of cannabinoids in the treatment of epilepsy , 2017, Epilepsy & Behavior.

[16]  M. Nagarkatti,et al.  Combination of cannabinoids, Δ9- tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigate experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. , 2017, The Journal of Immunology.

[17]  M. Raish,et al.  Potential Health Benefits and Metabolomics of Camel Milk by GC-MS and ICP-MS , 2016, Biological Trace Element Research.

[18]  C. Andre,et al.  Cannabis sativa: The Plant of the Thousand and One Molecules , 2016, Front. Plant Sci..

[19]  M. Raish,et al.  Metabolomic and elemental analysis of camel and bovine urine by GC–MS and ICP–MS , 2015, Saudi journal of biological sciences.

[20]  Takeshi Saito,et al.  Comprehensive review of the detection methods for synthetic cannabinoids and cathinones , 2015, Forensic Toxicology.

[21]  S. Mezouari,et al.  Development and validation of an improved method for the determination of chloropropanols in paperboard food packaging by GC-MS , 2015, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[22]  R. Padalia,et al.  The Essential Oil of 'bhang' ( Cannabis sativa L.) for Non-Narcotic Applications , 2014 .

[23]  K. Mackie,et al.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system , 1998, Neuroscience.

[24]  S. Galiègue,et al.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.

[25]  Y. Kloog,et al.  Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Elsohly,et al.  Phytochemistry of Cannabis sativa L. , 2017, Progress in the chemistry of organic natural products.

[27]  S. Paterson,et al.  Production of identical retention times and mass spectra for {delta}9-tetrahydrocannabinol and cannabidiol following derivatization with trifluoracetic anhydride with 1,1,1,3,3,3-hexafluoroisopropanol*. , 2012, Journal of analytical toxicology.